Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target
STAAR Surgical Co STAA
$24.36
▲ +0.58%
(+$0.14)
⬆️ Above Yest. High
📅 Earnings This Week
Open
$24.36
Prev Close
$24.22
Day Range
$23.74 – $24.61
52W Range
$15.59 – $35.87
Market Cap
$1.21B
Beta
1.24
EPS (TTM)
$-0.43
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1992-02-24 |
| Shares Out. | 49,790,000 |
| Website | staar.com/ ↗ |
| Phone | 16263037902 |
| Employees | 957 |
| Revenue | $93.5M |
| Gross Profit | $68.9M |
| Net Income | $5.2M |
| Free Cash Flow | -$55.0M |
| Total Assets | $451.1M |
| Total Liabilities | $98.8M |
| Equity | $352.4M |
About STAAR Surgical Co
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
STAAR Surgical Co is a publicly traded company under the ticker symbol STAA on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
17 analysts (2026-07-01)